ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 50 filers reported holding ATYR PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,565,445 | -38.9% | 1,171,436 | -16.3% | 0.43% | -33.3% |
| Q3 2022 | $4,197,000 | +6.0% | 1,398,889 | 0.0% | 0.65% | -16.9% |
| Q2 2022 | $3,959,000 | -47.1% | 1,398,889 | 0.0% | 0.78% | -35.6% |
| Q1 2022 | $7,484,000 | -36.0% | 1,398,889 | -10.6% | 1.21% | -24.2% |
| Q4 2021 | $11,691,000 | -17.7% | 1,565,000 | 0.0% | 1.60% | -12.4% |
| Q3 2021 | $14,210,000 | – | 1,565,000 | – | 1.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 624,000 | $1,367 | 2.16% |
| Tikvah Management LLC | 1,350,833 | $2,958,324 | 1.41% |
| VR Adviser, LLC | 1,171,436 | $2,565,445 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 123,430 | $270,312 | 0.04% |
| FEDERATED HERMES, INC. | 5,231,600 | $11,457,204 | 0.03% |
| Alyeska Investment Group, L.P. | 1,378,747 | $3,019,456 | 0.03% |
| Walleye Capital LLC | 750,000 | $1,642,500 | 0.03% |
| Tower Research Capital LLC (TRC) | 17,443 | $38 | 0.00% |
| CITIGROUP INC | 428,460 | $938,327 | 0.00% |
| PFS Partners, LLC | 406 | $890 | 0.00% |